The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-Amino-1-(3-(cyclopropanecarboxamido)phenyl)-1H-pyrrolo[2,3-b]quinoxaline-3-carboxamide ID: ALA3321810
PubChem CID: 118709762
Max Phase: Preclinical
Molecular Formula: C21H18N6O2
Molecular Weight: 386.42
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: NC(=O)c1c(N)n(-c2cccc(NC(=O)C3CC3)c2)c2nc3ccccc3nc12
Standard InChI: InChI=1S/C21H18N6O2/c22-18-16(19(23)28)17-20(26-15-7-2-1-6-14(15)25-17)27(18)13-5-3-4-12(10-13)24-21(29)11-8-9-11/h1-7,10-11H,8-9,22H2,(H2,23,28)(H,24,29)
Standard InChI Key: AGFAHKSTBACDOB-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 33 0 0 0 0 0 0 0 0999 V2000
2.8864 -15.4862 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.6010 -15.0737 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6010 -14.2487 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8864 -13.8362 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.1720 -14.2487 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4575 -13.8362 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7430 -14.2487 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7430 -15.0737 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4575 -15.4862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1720 -15.0737 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3856 -15.3288 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.3856 -13.9938 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8705 -14.6612 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6405 -13.2092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0885 -12.5961 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.4374 -12.9957 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.6405 -16.1133 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0885 -16.7264 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3434 -17.5110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1504 -17.6825 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7024 -17.0694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4475 -16.2848 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6955 -14.6612 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.5094 -17.2410 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.7644 -18.0256 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5713 -18.1971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2123 -18.6387 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.1850 -18.7478 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3565 -17.9409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
1 10 1 0
5 10 1 0
12 13 2 0
11 13 1 0
2 11 1 0
3 12 1 0
14 15 2 0
14 16 1 0
12 14 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
17 22 2 0
11 17 1 0
13 23 1 0
21 24 1 0
24 25 1 0
25 26 1 0
25 27 2 0
28 26 1 0
29 28 1 0
26 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 386.42Molecular Weight (Monoisotopic): 386.1491AlogP: 2.60#Rotatable Bonds: 4Polar Surface Area: 128.92Molecular Species: NEUTRALHBA: 6HBD: 3#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 5#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.59CX Basic pKa: 1.01CX LogP: 2.81CX LogD: 2.81Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.50Np Likeness Score: -1.81
References 1. Unzue A, Dong J, Lafleur K, Zhao H, Frugier E, Caflisch A, Nevado C.. (2014) Pyrrolo[3,2-b]quinoxaline derivatives as types I1/2 and II Eph tyrosine kinase inhibitors: structure-based design, synthesis, and in vivo validation., 57 (15): [PMID:25076195 ] [10.1021/jm5009242 ]